Charles River Laboratories | CRL - Stock


Charles River Laboratories reported $359.72M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Agilent USD 1.09B 30M Mar/2026
Align Technology USD 214.94M 11.4M Mar/2026
Bio-Rad Laboratories USD 770.5M 29.8M Mar/2026
Bruker USD 1.12B 26.9M Mar/2026
Cardinal Health USD 18.01B 2.11B Mar/2026
Charles River Laboratories USD 359.72M 60.62M Mar/2026
Cigna USD 5.83B 1.51B Mar/2026
CVS Health USD 17.77B 1.48B Mar/2026
Danaher USD 2.61B 119M Mar/2026
Dentsply International USD 659M 17M Mar/2026
Elevance Health USD 0 0 Dec/2024
Illumina USD 611M 47M Mar/2026
Incyte USD 115.62M 14.56M Mar/2026
Intrexon USD 287K 68K Dec/2022
Laboratory Of America USD 497.7M 37M Mar/2026
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
McKesson USD 24.21B 2.86B Mar/2026
Merck EUR 4.56B 52M Dec/2025
Mettler Toledo International USD 404.83M 17.6M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Quest Diagnostics USD 225M 36M Mar/2026
Revvity USD 387.5M 8.01M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
United Therapeutics USD 178.3M 4.8M Mar/2026
UnitedHealth USD 280M 280M Dec/2023
Waters USD 1.5B 923.63M Mar/2026
West Pharmaceutical Services USD 452.6M 8.7M Mar/2026